Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	«REMEDIUM GROUP» Ltd. 2023-01-01
Σειρά:	Атеротромбоз
Θέματα:	active cancer multifocal atherosclerosis d-dimer gdf-15 vegf-a prognosis determining outcomes
Διαθέσιμο Online:	https://www.aterotromboz.ru/jour/article/view/287

Παρόμοια τεκμήρια

GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register
ανά: Elena N. Krivosheeva, κ.ά.
Έκδοση: (2024-07-01)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
ανά: E. N. Krivosheeva, κ.ά.
Έκδοση: (2021-08-01)

Serum Concentration of Growth Differentiation Factor 15 and Atherosclerosis among General Older Japanese Individuals with Normal Weight
ανά: Yuji Shimizu, κ.ά.
Έκδοση: (2023-05-01)

Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
ανά: Sarah Mazin Naeem, κ.ά.
Έκδοση: (2024-12-01)

Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
ανά: S. S. Vedenskaya, κ.ά.
Έκδοση: (2024-12-01)

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
ανά: Léna Royston, κ.ά.
Έκδοση: (2022-08-01)

Interrelation of growth/differentiation factor-15 level with laboratory and clinical and functional parameters of patients with coronary artery disease
ανά: E. A. Zakharyan
Έκδοση: (2023-06-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
ανά: V. V. Genkel, κ.ά.
Έκδοση: (2021-03-01)

Determinants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease
ανά: Emma Skau, κ.ά.
Έκδοση: (2024-12-01)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
ανά: Lena Mathews, κ.ά.
Έκδοση: (2023-03-01)

Diagnosis of multifocal atherosclerosis in low-to moderate-risk patients and their restratification
ανά: O. V. Fatenkov, κ.ά.
Έκδοση: (2020-11-01)

Features of atherosclerosis in carotid and coronary arteries
ανά: E. V. Konstantinova, κ.ά.
Έκδοση: (2021-10-01)

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
ανά: Olga O. Shakhmatova, κ.ά.
Έκδοση: (2023-11-01)

Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese
ανά: Shuai Zheng, κ.ά.
Έκδοση: (2023-04-01)

Diagnostic and prognostic significance of D-dimer in internal medicine
ανά: Yu A Fedotkina, κ.ά.
Έκδοση: (2003-12-01)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
ανά: Alaa Efat, κ.ά.
Έκδοση: (2022-05-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
ανά: Mousa Khalafi, κ.ά.
Έκδοση: (2023-08-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
ανά: Mousa Khalafi, κ.ά.
Έκδοση: (2023-08-01)

Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy
ανά: A. V. Frolov, κ.ά.
Έκδοση: (2014-06-01)

Strategy for endovascular treatment of a patient with combined coronary and carotid artery atherosclerosis: a case report
ανά: F. B. Shukurov, κ.ά.
Έκδοση: (2023-01-01)

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
ανά: O L Barbarash, κ.ά.
Έκδοση: (2019-12-01)

Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
ανά: S A Gracheva, κ.ά.
Έκδοση: (2014-10-01)

Association between Serum GDF-15 and Cognitive Dysfunction in Hemodialysis Patients
ανά: Hae Ri Kim, κ.ά.
Έκδοση: (2024-02-01)

Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
ανά: Bina Albuquerque, κ.ά.
Έκδοση: (2022-03-01)

Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia
ανά: Jingru Cheng, κ.ά.
Έκδοση: (2023-03-01)

Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris
ανά: Mustafa Kaan Taşolar, κ.ά.
Έκδοση: (2021-12-01)

Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity
ανά: Mohamed Asrih, κ.ά.
Έκδοση: (2022-07-01)

Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
ανά: V V Genkel, κ.ά.
Έκδοση: (2019-10-01)

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE
ανά: K. S. Shafranskaya, κ.ά.
Έκδοση: (2015-03-01)

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
ανά: O. L. Barbarash, κ.ά.
Έκδοση: (2020-09-01)

A patient with сoronary artery disease and multifocal atherosclerosis. How to optimize the prognosis?
ανά: O. L. Barbarash, κ.ά.
Έκδοση: (2018-09-01)

Markers of hemostasis activation and endothelial damage in patients with active cancer
ανά: A. B. Dobrovolsky, κ.ά.
Έκδοση: (2022-06-01)

Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM
ανά: Jesús Cadenas, κ.ά.
Έκδοση: (2022-08-01)

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients
ανά: Elena A. Klesareva, κ.ά.
Έκδοση: (2022-05-01)

Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
ανά: Christopher R. deFilippi, κ.ά.
Έκδοση: (2023-02-01)

Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study
ανά: Ali Boustani, κ.ά.
Έκδοση: (2025-01-01)

SHORT-TERM RESULTS OF CARDIOSYNCHRONIZED CONSEQUENTIAL ANTEGRADE PNEUMOCOMPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
ανά: O. U. Atkov, κ.ά.
Έκδοση: (2015-03-01)

Maternal levels of growth differentiation factor-15 in patients with preeclampsia
ανά: Ilkbal Temel Yuksel, κ.ά.
Έκδοση: (2018-10-01)

Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients
ανά: Heba M. Adel Abou Zaghla, κ.ά.
Έκδοση: (2021-01-01)

SURGICAL TREATMENT OF MULTIFOCAL ATHEROSCLEROSIS: CORONARY AND BRACHIOCEPHALIC PATHOLOGY AND PREDICTORS OF EARLY ADVERSE EVENTS DEVELOPMENT
ανά: R. S. Tarasov, κ.ά.
Έκδοση: (2017-08-01)